drug · gene
obecabtagene autoleucel
Phase 3updated 3mo agoby $AUTL Autolus Therapeutics plc🔗 ChEMBL
Phase 3community read0 votes
Gene drug with a maximum clinical stage of Approval (across all indications), with an approval for b-cell acute lymphoblastic leukemia and 3 investigational indications.
targets
B-lymphocyte antigen CD19
all catalysts(0)
nothing on the calendar yet
Trials studying obecabtagene autoleucel
- phase2A Study of Obecabtagene Autoleucel in People With B-cell Acute Lymphoblastic Leukemia
- phase1Obe-cel in Refractory Progressive Forms of Multiple Sclerosis
- phase1Obe-cel in Adolescent [Applicable in UK Only] and Adult Severe, Refractory Systemic Lupus Erythematosus
- —Expanded Access Program for OOS Obe-cel
- phase2Obe-cel in Severe, Refractory Systemic Lupus Erythematosus With Active Lupus Nephritis
News(0)
no news has mentioned this drug yet
Data sources
last refreshed 1h ago
Found something off?
comments(0)
5-min edit window · permanent after that